Trial Profile
Clinical Trials Insight: 700050955
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Nov 2009
Price :
$35
*
At a glance
- Drugs Oxybutynin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 14 Nov 2009 New trial record.